Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
EPS (Diluted)
Novo Nordisk A/S
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novo Nordisk A/S
CSE:NOVO B
|
EPS (Diluted)
kr18
|
CAGR 3-Years
27%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
H Lundbeck A/S
CSE:HLUN A
|
EPS (Diluted)
kr2
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ALK-Abello A/S
CSE:ALK B
|
EPS (Diluted)
kr2
|
CAGR 3-Years
171%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's EPS (Diluted)?
EPS (Diluted)
18.6
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's EPS (Diluted) amounts to 18.6 DKK.
What is Novo Nordisk A/S's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
15%
Over the last year, the EPS (Diluted) growth was 52%. The average annual EPS (Diluted) growth rates for Novo Nordisk A/S have been 27% over the past three years , 18% over the past five years , and 15% over the past ten years .